Lexeo Therapeutics, Inc. LXEO
- LX1001 — Alzheimer's Disease Phase 1
- LX1021 — Alzheimer's Disease Preclinical
- LX1020 — Alzheimer's Disease Preclinical
APOE4 (1 companies · 3 programs)
Companies with an active program directed at APOE4.
Companies with an active program directed at APOE4.